Mahadevia Ankit
Insider CIK 1720974 · SPRO See Remarks, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPRO Spero Therapeutics, Inc. | S Sale | 2025-08-28 | 2025-09-03 | 6,572 | $1.97 | $12.9K | 703,294 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2025-06-12 | 2025-06-16 | 20,000 | — | $0 | 709,866 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2025-02-05 | 2025-02-05 | 55,260 | $0.78 | $43.1K | 689,866 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2025-02-05 | 2025-02-05 | 13,959 | $0.78 | $10.9K | 745,126 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2024-08-27 | 2024-08-29 | 5,912 | $1.35 | $8.0K | 759,085 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2024-05-29 | 2024-05-30 | 20,000 | — | $0 | 764,997 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2024-02-02 | 2024-02-05 | 63,795 | $1.37 | $87.4K | 744,997 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2023-10-05 | 2023-10-10 | 20,000 | — | $0 | 808,792 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2023-08-28 | 2023-08-30 | 9,040 | $1.26 | $11.4K | 788,792 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2023-02-03 | 2023-02-06 | 12,286 | $1.81 | $22.2K | 797,832 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2023-02-01 | 2023-02-03 | 531,914 | — | $0 | 810,118 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-02-03 | 187,730 | — | $0 | 187,730 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2022-02-01 | 2022-02-03 | 134,168 | — | $0 | 278,204 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2021-12-27 | 2021-12-29 | 8,000 | — | $0 | 486,809 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2021-12-27 | 2021-12-29 | 8,000 | $5.90 | $47.2K | 152,036 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2021-12-27 | 2021-12-29 | 8,000 | $14.58 | $116.6K | 144,036 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2021-08-26 | 2021-08-30 | 78,219 | — | $0 | 144,036 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2021-02-01 | 2021-02-03 | 179,319 | — | $0 | 179,319 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2020-11-04 | 2020-11-05 | 7,370 | — | $0 | 494,809 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2020-11-04 | 2020-11-05 | 7,370 | $5.90 | $43.5K | 73,187 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2020-11-04 | 2020-11-05 | 7,370 | $14.43 | $106.3K | 65,817 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2020-11-03 | 2020-11-05 | 2,137 | — | $0 | 502,179 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2020-11-03 | 2020-11-05 | 2,137 | $5.90 | $12.6K | 67,954 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2020-11-03 | 2020-11-05 | 2,137 | $14.27 | $30.5K | 65,817 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2020-10-23 | 2020-10-27 | 20 | — | $0 | 504,316 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2020-10-23 | 2020-10-27 | 20 | $5.90 | $118 | 65,837 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2020-10-23 | 2020-10-27 | 20 | $14.25 | $285 | 65,817 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2020-10-14 | 2020-10-15 | 105 | — | $0 | 504,336 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2020-10-14 | 2020-10-15 | 105 | $5.90 | $620 | 65,922 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2020-10-14 | 2020-10-15 | 105 | $14.25 | $1.5K | 65,817 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2020-10-13 | 2020-10-15 | 14,367 | — | $0 | 504,441 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2020-10-13 | 2020-10-15 | 14,367 | $14.28 | $205.2K | 65,817 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2020-10-13 | 2020-10-15 | 14,367 | $5.90 | $84.8K | 80,184 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2020-09-08 | 2020-09-10 | 774 | — | $0 | 518,808 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2020-09-08 | 2020-09-10 | 774 | $14.25 | $11.0K | 65,817 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2020-09-08 | 2020-09-10 | 774 | $5.90 | $4.6K | 66,591 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2020-07-09 | 2020-07-09 | 2,293 | — | $0 | 519,582 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2020-07-09 | 2020-07-09 | 2,293 | $14.31 | $32.8K | 65,817 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2020-07-09 | 2020-07-09 | 2,293 | $5.90 | $13.5K | 68,110 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2020-07-07 | 2020-07-09 | 754 | — | $0 | 521,875 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2020-07-07 | 2020-07-09 | 754 | $5.90 | $4.4K | 66,571 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2020-07-07 | 2020-07-09 | 754 | $14.25 | $10.7K | 65,817 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2020-06-25 | 2020-06-29 | 2,642 | — | $0 | 522,629 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2020-06-25 | 2020-06-29 | 2,642 | $14.25 | $37.6K | 65,817 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2020-06-25 | 2020-06-29 | 2,642 | $5.90 | $15.6K | 68,459 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2020-06-24 | 2020-06-29 | 3,880 | — | $0 | 525,271 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2020-06-24 | 2020-06-29 | 3,880 | $5.90 | $22.9K | 69,697 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2020-06-24 | 2020-06-29 | 3,880 | $14.28 | $55.4K | 65,817 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2020-06-23 | 2020-06-29 | 8,045 | — | $0 | 529,151 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2020-06-23 | 2020-06-29 | 8,045 | $14.33 | $115.3K | 65,817 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2020-06-23 | 2020-06-29 | 8,045 | $5.90 | $47.5K | 73,862 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2020-06-22 | 2020-06-29 | 2,613 | — | $0 | 537,196 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2020-06-22 | 2020-06-29 | 2,613 | $14.30 | $37.4K | 65,817 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2020-06-22 | 2020-06-29 | 2,613 | $5.90 | $15.4K | 68,430 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2020-02-03 | 2020-02-03 | 180,000 | — | $0 | 180,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2019-01-02 | 2019-01-02 | 180,000 | — | $0 | 180,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2018-07-06 | 2018-07-06 | 1,600 | — | $0 | 118,888 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2018-07-06 | 2018-07-06 | 100 | $17.62 | $1.8K | 66,317 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2018-07-06 | 2018-07-06 | 1,600 | $5.90 | $9.4K | 67,417 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2018-07-06 | 2018-07-06 | 100 | $17.55 | $1.8K | 66,817 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2018-07-06 | 2018-07-06 | 500 | $17.50 | $8.8K | 66,917 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2018-07-06 | 2018-07-06 | 400 | $17.58 | $7.0K | 66,417 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2018-07-06 | 2018-07-06 | 200 | $17.92 | $3.6K | 65,817 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2018-07-06 | 2018-07-06 | 200 | $17.90 | $3.6K | 66,017 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2018-07-06 | 2018-07-06 | 100 | $17.71 | $1.8K | 66,217 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise deriv | 2018-07-05 | 2018-07-06 | 3,076 | — | $0 | 120,488 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2018-07-05 | 2018-07-06 | 3,076 | $17.62 | $54.2K | 65,817 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | M Exercise | 2018-07-05 | 2018-07-06 | 3,076 | $5.90 | $18.1K | 68,893 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2017-12-13 | 2017-12-15 | 125,079 | — | $0 | 125,079 | SEC↗ |